Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells (Q44607712)

4 December 2017

title

Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells (English)

1 reference

4 December 2017

main subject

chronic myeloid leukemia

0 references

1 reference

1 reference

Theresia M Westers

1

1 reference

4 December 2017

Willemijn van den Ancker

2

1 reference

4 December 2017

Hetty J Bontkes

3

1 reference

4 December 2017

Jeroen J W M Janssen

4

1 reference

4 December 2017

Arjan A van de Loosdrecht

5

1 reference

4 December 2017

Gert J Ossenkoppele

6

1 reference

4 December 2017

publication date

1 April 2011

1 reference

4 December 2017

1 reference

4 December 2017

volume

3

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

569-576

1 reference

Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alpha

4 December 2017

cites work

1 reference

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

21 January 2018

1 reference

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

21 January 2018

1 reference

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

21 January 2018

1 reference

Graft-versus-leukemia effects of transplantation and donor lymphocytes

21 January 2018

1 reference

T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.

21 January 2018

1 reference

The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells

21 January 2018

1 reference

Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.

21 January 2018

1 reference

Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.

21 January 2018

1 reference

Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration

21 January 2018

1 reference

Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of imatinib mesylate: implication for vaccination regimens

21 January 2018

1 reference

Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia

21 January 2018

1 reference

Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation

21 January 2018

1 reference

Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses

21 January 2018

1 reference

Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia

21 January 2018

1 reference

Inhibiting effects on the induction of cytotoxic T lymphocytes by dendritic cells pulsed with lysates from acute myeloid leukemia blasts

21 January 2018

1 reference

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination

21 January 2018

1 reference

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

21 January 2018

1 reference

Insights into the stem cells of chronic myeloid leukemia

21 January 2018

1 reference

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

21 January 2018

1 reference

Priming with dendritic cells can generate strong cytotoxic T cell responses to chronic myelogenous leukemia cells in vitro

21 January 2018

1 reference

Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.

21 January 2018

1 reference

Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib

21 January 2018

1 reference

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.11.3

1 reference

4 December 2017

1 reference